www.fdanews.com/articles/82119-cambridge-antibody-technology-group-plc-acquires-oncology-product-candidates
CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC ACQUIRES ONCOLOGY PRODUCT CANDIDATES
November 2, 2005
Cambridge Antibody Technology is buying two experimental cancer drugs from a unit of Denmark's Danisco for up to $16 million to boost its drugs pipeline, the UK biotech firm said on Tuesday. CAT said it was buying GCR-3888, which is in intermediate Phase II clinical trials for hairy cell leukemia (HCL), and GCR-8015, a preclinical treatment for cancers including non-Hodgkin's lymphoma, from Danisco's Genencor unit.
ABC News (http://abcnews.go.com/Health/wireStory?id=1269632)